LuciMava 2.5 MG (Mavacamten)

Description

Mavacamten

Each LuciMava capsule contains: Mavacamten … 2.5mg.

INDICATIONS

LuciMava is a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II -III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms.

DOSAGE AND USE

The recommended starting dose is 5 mg orally once daily without regard to food; allowable subsequent doses with titration are 2.5 mg, 5 mg, 10 mg, or 15 mg orally once daily. The maximum recommended dose is 15 mg orally once daily.Refer the full Prescribing information for detail instructions. Capsules should be swallowed whole & not chewed or crushed.

STORAGE

In a dry place and store at 20℃ to 25℃.

MANUFACTURED AND MARKETED BY

LUCIUS PHARMACEUTICALS(LAO) CO., LTD. No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNINGS

Keep medicine out of reach of Children. Do not administer LuciMava during Pregnancy and Lactation.